Finance News

Sagimet Biosciences’ DenifanStat should be more today (NASDAQ: SGMT)

This article is from

My name is Myrim Hernandez Alvarez. I received a degree in Electronics and Telecommunications Engineering from Escuela Political Institution, a Bachelor of Computer Science from Ohio University, Ohio, Ohio University, and a Bachelor of Graduate Degree in Business Administration from Andina andina Simon Bolivar, Quito, Ecuador University, and a Ph.D. Bachelor of Computer Applications from the University of Alicante, Spain. Disclosure: I work professionally with Edgar Torres H, who is also the author of seeking Alpha. Our analysis is conducted independently and we insist on seeking Alpha’s common association guidelines.

Analysts’ disclosure: I/We have no stock, options or similar derivatives positions in any of the companies mentioned, nor have any plans to initiate any such positions within the next 72 hours. I wrote this article myself and expressed my opinions. I was not compensated (other than seeking alpha). I have no business relationship with any of the companies mentioned in this article.

Seeking Alpha’s disclosure: Past performance cannot guarantee future results. There are no suggestions or suggestions as to whether any investment is suitable for a particular investor. Any view or view expressed above may not reflect the view of Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or U.S. investment advisor or investment bank. Our analysts are third-party authors, including professional and individual investors, who may not be licensed or certified by any institute or regulatory authority.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
×